Why the study?
Cancer patients face a high risk of developing ACS, but there are a limited number of studies guiding management.
Highlights the need for interdisciplinary management and personalized antitumor therapy to mitigate the high risk of acute coronary syndrome in cancer patients.
The purpose of this work is to increase the alertness of doctors treating cancer patients due to the high risk of developing acute coronary syndrome (ACS) and understanding the pathogenetic mechanisms of the development of ACS. Antitumor therapy should be personalized and agreed upon by an interdisciplinary team with an assessment of the impact on the risk of developing ACS, especially in patients with high cardiovascular risk. Given the limited number of studies, principles for the management of cancer patients with ACS should be based on an assessment of ischemic and hemorrhagic risks.
No takes yet. Share an insight, caveat, or question.
Bliznyuk et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: